-
公开(公告)号:US08604038B2
公开(公告)日:2013-12-10
申请号:US13392282
申请日:2010-08-24
申请人: Scott D. Edmondson , Lehua Chang , Nam Fung Kar , Gergori J. Morriello , Christopher R. Moyes , Dong-Ming Shen , Cheng Zhu , Neville J. Anthony , Philip Jones , Graham F. Smith , Mark E. Scott , Christopher F. Thompson , Joon Jung , Carolyn Cammarano , Dawn Marie Hoffman
发明人: Scott D. Edmondson , Lehua Chang , Nam Fung Kar , Gergori J. Morriello , Christopher R. Moyes , Dong-Ming Shen , Cheng Zhu , Neville J. Anthony , Philip Jones , Graham F. Smith , Mark E. Scott , Christopher F. Thompson , Joon Jung , Carolyn Cammarano , Dawn Marie Hoffman
IPC分类号: A61K31/50 , A61K31/525
CPC分类号: C07D401/12 , C07D207/08 , C07D403/12 , C07D413/12 , C07D417/12 , C07D471/04
摘要: The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
摘要翻译: 本发明提供式(I)的化合物,其药物组合物及其用于治疗或预防由β3肾上腺素受体激活介导的疾病的方法。